Indeed, given that CTSD retains its catalytic activity at neutral pH [16], these data indicate a potential role for extracellular CTSD in lipid-related disorders such as NAFLD [17,18]. The gene discussed is CTSD; the disease is metabolic dysfunction-associated steatotic liver disease.